9th Cir.;
15-16380

The court of appeals reversed a judgment. The court held that relators adequately alleged a drug manufacturer's violations of the False Claims Act.

Jeffrey and Sherlyn Campie filed a qui tam action against drug manufacturer Gilead Sciences, Inc., alleging that Gilead made false statements about its compliance with Food and Drug Administration (FDA) regulations regarding certain HIV drugs, resulting in the receipt of billions of dollars from the government. The Campies, former Gilead employees, alleged that these noncompliant drugs were not eligible to receive payment or reimbursement and, therefore, any claims presented to the government for payment were false under the False Claims Act. The Campies further alleged that Gilead violated the False Claims Act when it fired Jeffrey, who discovered and ultimately reported the violations.